Xiangxue Pharmaceutical Co.,Ltd. (SZSE: 300147)
Health Care · Pharmaceuticals · CN
CN¥6.88
-8.63% today · -34.1% 1Y
Xiangxue Pharmaceutical Co.,Ltd. (SZSE: 300147) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $676.78M and employs 2,662 people.
Over the last twelve months the share price has lost 34.1%, trading between 5.90 and 12.79.
Tweenvest scores Xiangxue Pharmaceutical Co.,Ltd. across four factors: quality 41/100, value 45/100, growth 4/100. Its strongest factor is value.
300147 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $676.78M
- Revenue (TTM)
- $221.61M
- P/E
- —
- EPS
- -2.16
- Dividend yield
- —
- Beta (5Y)
- 0.56
- 52-week high
- CN¥12.79
- 52-week low
- CN¥5.90
- Avg volume (3M)
- —
- Shares outstanding
- 661.28M
- Employees
- 2,662
- Next earnings
- —
About Xiangxue Pharmaceutical Co.,Ltd.
Xiangxue Pharmaceutical Co., Ltd. is actively involved in the full pharmaceutical lifecycle within China, from scientific research and product development to sourcing, production, and market distribution. The company's product portfolio notably includes its branded Xiangxue antivirotic oral liquids. Beyond these pharmaceutical offerings, it also provides a variety of healthcare supplements and comprehensive wellness solutions, such as specialized food and beverage items. Xiangxue Pharmaceutical has forged a strategic alliance with 111, Inc., with the aim of advancing an "Internet + Medicine" framework tailored for China's traditional Chinese medicine industry. The firm was established in 1997 and its main operations are based in Guangzhou, China.
- ISIN
- CNE100000Y92
- Founded
- 1986
- Listed since
- Dec 15, 2010
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,256.11 | +0.06% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.93 | +0.63% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.78 | +0.15% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.